Zinc Patents (Class 424/641)
-
Patent number: 7989003Abstract: A viscous gel for delivering minor effective amounts of active substances through the nasal membrane into the body.Type: GrantFiled: October 14, 2010Date of Patent: August 2, 2011Assignee: Zicam, LLCInventors: Charles Hensley, Robert Steven Davidson
-
Publication number: 20110182885Abstract: A formulation for well-being in humans including: extracts from the herbal varieties, Polygonum multiflorum, Panax quinquefolium, Gingko biloba, and Equisetum arvense; beta sitosterol methyl sulfonyl methane; soy isoflavones; levo-arginine; inositol; niacin; pantothenic acid or salts thereof; alpha-tocopherol; biotin; pyridoxine hydrochloride zinc (or amino acid chelate thereof); and colostrum.Type: ApplicationFiled: April 8, 2011Publication date: July 28, 2011Inventor: Jon PHILLIPS
-
Publication number: 20110183006Abstract: The present invention provides compositions and methods for treatment of abnormal conditions in a subject, wherein the abnormal condition affects the musculoskeletal joints of the subject.Type: ApplicationFiled: July 20, 2009Publication date: July 28, 2011Applicant: Hills Pet Nutrition, Inc.Inventors: Ryan Michael Yamka, Nolan Zebulon Frantz, Xiangming Gao, Samer Al-Murrani
-
Publication number: 20110183008Abstract: A pure lactoferrin polypeptide containing no more than two metal ions per molecule, or a mixture of the polypeptide and a fragment thereof. The polypeptide or the mixture stimulates skeletal growth and inhibits bone resorption. Also disclosed is a method of treating a bone-related disorder with the polypeptide or the mixture.Type: ApplicationFiled: April 7, 2011Publication date: July 28, 2011Inventors: JILLIAN CORNISH, IAN REGINALD REID, KATE PATRICIA PALMANO, NEILL WARD HAGGARTY
-
Publication number: 20110171188Abstract: The invention relates to a non-thermal plasma for treatment of a surface, particularly for the treatment of a wound (1), wherein the plasma comprises a partially ionized carrier gas and at least one additive, which preferably has a sterilizing effect on the treated surface and/or improves the healing of the wound (1). Further, the invention relates to a corresponding apparatus and method.Type: ApplicationFiled: August 17, 2009Publication date: July 14, 2011Applicant: Max-Planck-Gesellschaft zur Foerderung der Wissenschaften e.VInventors: Gregor Morfill, Bernd Steffes, Tetsuji Shimizu, Rene Pompl, Tetiana Nosenko, Wilhelm Stolz, Georg Isbary, Hans-Ulrich Schmidt
-
Patent number: 7976876Abstract: The present invention relates to an anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use. The composition of the present invention mainly includes the following three ingredients in an adequate ratio: (A) a metal compound having a catalytic function; (B) a mixture of a coenzyme having reducing ability and a quinone, and (C) an additive. The anti-bacterial, anti-virus, and anti-fungus composition of the present invention is capable of destroying viruses as well as killing bacterial and fungi. Therefore, the composition can be formulated as an aerosol and a film for applying to protection devices such as respirators, masks, gloves, filters, condoms, etc. The present composition can also be used in household, vehicle, hospital, school, restaurant, hotel, internet coffee shop for applying to filter of air-conditioner, tap, stool, interior of elevator and its keyboard.Type: GrantFiled: September 29, 2008Date of Patent: July 12, 2011Assignee: Well-Being Biochemical Corp.Inventors: Jih-ru Hwu, Shwu-chen Tsay
-
Publication number: 20110159108Abstract: Described herein is a beverage lid that is itself treated with and/or impregnated with antimicrobial material to prevent the spread of contaminants and methods of making and using the same. The beverage lid can prevent spread of contaminants, including communicable diseases like influenza, the common cold, streptococcus or staphylococcus. For example, when a person carrying germs, like influenza, touches a beverage lid, the antimicrobial properties of the beverage lid can combat any contamination of the beverage lid by the germs. Another person can drink from the beverage lid that is substantially germ free.Type: ApplicationFiled: September 15, 2010Publication date: June 30, 2011Inventors: Michael J. Maczuzak, Kathryn Jeanne Neiheiser, Cherry Bochmann
-
Publication number: 20110150968Abstract: A strip, which is both edible and dissolvable, is provided comprising a film and a dosage of at least 2% of the reference daily intake (RDI) of at least one dietary supplement for malnutrition or to prevent/treat alcohol induced hangovers. A method for treating malnutrition and/or preventing and treating alcohol-induced hangovers using a dissolvable orally administered strip.Type: ApplicationFiled: June 18, 2010Publication date: June 23, 2011Inventor: Alessandra Grassi
-
Publication number: 20110135729Abstract: The present invention relates to a method for controlling heat generation of a magnetic nanomaterial, comprising the steps of: (a) mixing (i) a nanomaterial precursor comprising a metal precursor material and a predetermined amount of a zinc precursor with (ii) a reaction solvent; and (b) preparing a zinc-containing magnetic nanomaterial from the mixture of step (a) comprising a zinc doped metal oxide nanomaterial matrix; and wherein a specific loss power of the zinc-containing magnetic nanomaterial is varied depending an amount of zinc to be doped, whereby the heat generation of the magnetic nanomaterial is controlled. In addition, the present invention relates to a heat-generating nanoparticle and a composition for hyperthermia. The present invention suggests a novel approach to improve a heat generation of a magnetic nanomaterial.Type: ApplicationFiled: May 20, 2009Publication date: June 9, 2011Applicant: Industry-Academic Cooperation Foundation Yonsei UniversityInventors: Jin Woo Cheon, Jung Tak Jang
-
Publication number: 20110135735Abstract: The invention relates to a process for production of a composite material having antimicrobial activity, having the following steps: provision of a metal powder produced from a metal having antimicrobial activity, wherein the metal powder is formed from discrete agglomerates having a porosity of 30 to 98%, wherein the agglomerates have a spongy structure formed by solid material bridges; melting a thermoplastic and setting a predetermined viscosity; mixing the metal powder with the molten thermoplastic in a predetermined quantitative ratio; and cooling the mixture, wherein the metal powder is firmly bound to a matrix formed by the plastic.Type: ApplicationFiled: June 25, 2009Publication date: June 9, 2011Applicant: BIO-GATE AGInventor: Peter Steinruecke
-
Publication number: 20110135701Abstract: The invention relates to cellulosic moldings having very finely distributed zinc pigments after the dry-wet extrusion method. Cellulosic moldings formed in accordance with the inventive methods, compared to unmodified cellulose fibers, have a high degree of whiteness combined with greatly increased UV light absorption and a wash-resistant bactericidal effect, while at the same time having unrestricted textile processability. The cellulosic functional moldings produced according to the invention are particularly suited for use in textiles for clothing, technical textiles, recreation, medicine, and cosmetics.Type: ApplicationFiled: August 25, 2009Publication date: June 9, 2011Inventors: Axel Kolbe, Hardy Markwitz
-
Patent number: 7951847Abstract: Provided are methods of treating HIV patients by administering to the patient a nutrient composition and at least one anti-retrovial drug. The method results in an increase in the patient's CD4+ cell count by at least 25% during a treatment period. The nutrient composition includes alpha lipoic acid; acetyl L-carnitine; N-acetyl-cysteine; zinc; selenium; vitamin C; bioflavinoid complex; vitamin E; one or more antioxidants selected from co-enzyme Q10 and glutathione; and one or more vitamins or minerals selected from beta-carotene, vitamin A, vitamin B1, vitamin B2, vitamin B6, niacinamide, calcium pantothenate, folic acid, vitamin B12, copper, manganese, chromium, and molybdenum.Type: GrantFiled: March 7, 2008Date of Patent: May 31, 2011Assignee: K-PAX Vitamins, Inc.Inventor: Jon D. Kaiser
-
Patent number: 7951840Abstract: The addition of low concentrations of combinations of water-soluble organic salts of zinc to gels, creams, lotions or ointments can increase the ability of these products to reduce or prevent exogenous irritants from causing irritation of the underlying substrate. The addition of low concentrations of combinations of water-soluble organic zinc salts to these gels, creams, lotions or ointments also can reduce the irritation of skin or mucous membranes caused by the addition of potentially-irritating substances such as spermicides, microbicides, fungicides or other therapeutic agents to the gel, cream, lotion or ointment. The advantages of this anti-irritant approach over others, which generally employ high concentrations of single zinc salts, are the reduced potential for zinc toxicity, the reduced potential for toxicity related to zinc itself, and the preservation of the desirable biological properties of potentially-irritating therapeutic substances added to the gel, cream, lotion or ointment.Type: GrantFiled: July 17, 2003Date of Patent: May 31, 2011Inventors: Shanta M. Modak, Milind S. Shintre, Lauser Caraos, Trupti Gaonkar
-
Publication number: 20110123643Abstract: An antifouling barrier comprising a silicon bronze alloy, the silicon bronze alloy comprising about 0.5% to about 3.8% silicon (wt/wt alloy) and greater than about 90% copper (wt/wt alloy). In some embodiments, the silicon bronze alloy additionally comprises from about 0.05% to about 1.3% manganese (wt/wt alloy). The antifouling barrier may be a welded wire mesh, screen, chain-link, chain-mail, grid, weave, perforated sheet, or chicken wire. Methods of reducing the growth of an organism on an animal enclosure, comprising contacting at least a portion of the animal enclosure with an antifouling barrier comprising a silicon bronze alloy comprising about 0.5% to about 3.8% silicon (wt/wt alloy) and greater than about 90% copper (wt/wt alloy).Type: ApplicationFiled: November 24, 2009Publication date: May 26, 2011Inventors: Robert A. Biersteker, John J. Stevens, Carl J. Michalewski, Robert F. Cyra
-
Publication number: 20110123589Abstract: In the present invention nanocomposite materials in form of three-dimensional structure formed by a polymeric matrix consisting of a polysaccharidic composition of neutral or anionic polysaccharides and a branched cationic polysaccharides, in which metallic nanoparticles are uniformly dispersed and stabilized, are described. Using appropriate techniques of gelification or by means of an appropriate dehydration, the nanocomposite materials are three-dimensional matrices having different shapes in hydrated form as hydrogels, or in non-hydrated form. These nanocomposite materials have a broad-spectrum of strong bactericidal activity, but do not show any cytotoxicity.Type: ApplicationFiled: July 22, 2009Publication date: May 26, 2011Applicant: Universita Degil Studi di TriesteInventors: Ivan Donati, Eleonora Marsich, Andrea Travan, Sergio Paoletti
-
Publication number: 20110111005Abstract: The present invention relates to a biocompatible ceramic material comprising Sr, Mg or Ba doped Hardystonite (Ca2ZnSi2O7), and a method for its synthetic preparation. The present invention also relates to an implantable medical device comprising biocompatible doped Hardystonite, and a method for its production. The present invention further relates to a method for improving the long term stability of an implantable medical device and an implantable drug delivery device comprising doped Hardystonite. Further, the present invention relates to the use of comprising biocompatible doped Hardystonite in the regeneration or resurfacing of tissue.Type: ApplicationFiled: July 10, 2009Publication date: May 12, 2011Applicant: The University of SydneyInventors: Hala Zreiqat, Chengtie Wu, Colin Dunstan
-
Patent number: 7939109Abstract: A method of treating neoplastic disease in a human or animal patient is provided comprising administering to the patient an anti-neoplastic effective amount of a composition comprising as the sole pharmaceutically active components (a) copper gluconate or copper orotate; (b) sodium salicylate; (c) vitamin C; (d) manganese gluconate or manganese orotate; and optionally one or more of (e) iron gluconate or iron orotate; (f) sublimed sulphur; and (g) zinc gluconate or zinc orotate.Type: GrantFiled: October 2, 2000Date of Patent: May 10, 2011Inventor: John Carter
-
Publication number: 20110097370Abstract: Disclosed is a method for preparing an antimicrobial composition for making filament for brushes. The method comprises steps in the following order: (1) mechanically pulverizing a polymer to obtain a polymer powder; (2) blending the polymer powder obtained in step (1) with an antimicrobial agent comprising phosphate, or glass, micropowder loaded with silver, zinc, or a silver-zinc composite.Type: ApplicationFiled: October 25, 2010Publication date: April 28, 2011Applicant: E. I. DU PONT DE NEMOURS AND COMPANY DUPONT XINGDA FILAMENTS COMPANY LIMITEDInventors: Mingsong Wang, Xianqiao Liu
-
Patent number: 7931910Abstract: The present invention provides an environmentally compatible, pesticidal composition and method for the control of insect pests. The composition includes two components. The first component is a chelating agent, a metal complex of a chelating agent, and mixtures thereof, and the second component is preferably a carrier material.Type: GrantFiled: January 17, 2007Date of Patent: April 26, 2011Assignee: W. Neudorff GmbH KGInventor: Diana L. Parker
-
Publication number: 20110091576Abstract: A method for the treatment and prophylaxis of conditions of aging due oxidative stress and as growth factors of stem cells. Such conditions due to oxidative stress are associated with a decreased presence of one or more cell-specific carbonic anhydrase enzymes in the tissue of a subject. Such conditions include but are not limited to alzheimer's disease, parkinson's disease, multiple sclerosis, autism, lou gehrig's disease, huntington's disease, diabetes mellitus, amyloid diseases, atherosclerosis, arthritis, osteoporosis, cystic fibrosis. The method comprises administering to the patient a pharmaceutically effective, non-toxic amount of one or more compounds that increases the presence of one or more Carbonic Anhydrase Isozymes whose levels have been reduced in the subject.Type: ApplicationFiled: December 4, 2010Publication date: April 21, 2011Inventor: Victorio C. Rodriguez
-
Patent number: 7927616Abstract: Pesticide compositions and methods for their use are provided. Embodiments of the subject pesticide compositions include a pesticide and an assimilable carbon skeleton energy component. Embodiments of the subject compositions may include a pesticide and one or more of a macronutrient component, micronutrient component, vitamin/cofactor component and a complexing agent. Also provided are methods that include preparing an assimilable carbon skeleton energy containing-pesticide composition and methods for administering an assimilable carbon skeleton energy containing-pesticide composition to a plant. Kits for use in practicing the subject invention are also provided. The subject pesticide compositions find use in a variety of different applications, and are particularly suited for use in at least mollifying pesticide-induced phytotoxicity of a plant.Type: GrantFiled: January 16, 2004Date of Patent: April 19, 2011Inventor: Thomas T. Yamashita
-
Patent number: 7927631Abstract: A formulation for well-being in humans including: extracts from the herbal varieties, Polygonum multiflorum, Panax quinquefolium, Gingko biloba, and Equisetum arvense; beta sitosterol methyl sulfonyl methane; soy isoflavones; levo-arginine; inositol; niacin; pantothenic acid or salts thereof; alpha-tocopherol; biotin; pyridoxine hydrochloride zinc (or amino acid chelate thereof); and colostrum.Type: GrantFiled: December 23, 2005Date of Patent: April 19, 2011Assignee: Dolphst Pty LtdInventor: Jon Phillips
-
Patent number: 7927614Abstract: Composition and methods for alleviating or eliminating age related skin conditions by providing an effective amount of one or more copper, zinc and copper-zinc compositions are disclosed. Treatment is accomplished through the use of topical compositions containing one or more copper or zinc salts and/or copper-zinc compounds or complexes, particularly copper-zinc malonate active ingredient.Type: GrantFiled: June 14, 2006Date of Patent: April 19, 2011Assignee: JR Chem, LLCInventors: Joseph R. Faryniarz, Jose E. Ramirez
-
Publication number: 20110082040Abstract: The present invention generally relates to compositions and methods of delivering substances in a dry mode. In one embodiment, the substance can be bacteria, enzymes, other microorganisms, or combinations thereof. The compositions that are in accordance with various embodiments of the present invention have varied uses, which can include delivering microorganisms to remove contaminates, such as oil, chemical, waste, or sewage, from soil, water, or air. In other embodiments, the substances can include liquid food, liquid food additives, liquid biotech agricultural ingredients, conventional liquid agricultural ingredients, liquid human wellness and dietary supplements, and liquid fragrances and beauty products.Type: ApplicationFiled: October 5, 2010Publication date: April 7, 2011Applicant: DAIRY MANUFACTURERS, INC.Inventors: Ramiro Trevino, Steven R. Ellis
-
Publication number: 20110070275Abstract: Although zinc pyrithione is known as an excellent antidandruff component, there is a demand for an effort to reduce the blending amount without lowering the effects from the viewpoint of environmental pollution. Also, there is a demand for developing a technique that enables combining zinc pyrithione with cuprous oxide to be used as an antifouling component for a ship-bottom paint. Moreover, also as an antiseptic and anti-mold component for polymer materials, further enhancement of the antimicrobial activity of zinc pyrithione has been demanded. It has been elucidated that a new composite of the present invention obtained by treating an aqueous suspension or an aqueous paste containing zinc pyrithione or a zinc pyrithione/zinc oxide complex compound and ultrafine zinc oxide having an average particle diameter of 0.01 to 0.15 ?M at pH 8 to 12 exerts an excellent physiologic/antibiotic activity such as an anti-dandruff and hair restoration effect and an underwater antifouling, antiseptic and anti-mold effect.Type: ApplicationFiled: May 27, 2009Publication date: March 24, 2011Inventor: Yasuhiro Hidaka
-
Patent number: 7910137Abstract: Metal carnitine chelates comprising carnitine chelated to a nutritionally relevant metal can be used for general nutrition as well as well as to treat a variety of health related problems and symptoms. For example, metal carnitine chelates can be used to maintain good cardiovascular health, increase male fertility, enhance weight loss, provide mineral and/or carnitine supplements for mineral- and/or carnitine-deficient subjects, and reduce alcohol dependency and associated symptoms. Nutritionally relevant metals that can be used include copper, zinc, magnesium, calcium, iron, chromium, and manganese, to name a few.Type: GrantFiled: July 7, 2006Date of Patent: March 22, 2011Assignee: Albion International, Inc.Inventors: H. DeWayne Ashmead, R. Charles Thompson
-
Publication number: 20110052662Abstract: In one embodiment, an antibacterial material includes at least one microparticles selected from tungsten oxide microparticles and tungsten oxide complex microparticles. The microparticles, which are undergone a test to evaluate viable cell count by inoculating in a test piece, to which the microparticles are adhered in a range of 0.02 mg/cm2 or more and 40 mg/cm2 or less, at least one bacterium selected from among Staphylococcus aureus, Escherichia coli, Klebsiella pneumoniae, Pseudomonas aeruginosa, methicillin-resistant Staphylococcus aureus, and enterohemorrhagic Escherichia coli, and storing for 24 hours, have an antibacterial activity value R of 0.1 or more expressed by the following: R=log(B1/C1) where, B1 denotes an average value (number) of viable cell count after storing an untreated test piece for 24 hours, and C1 denotes an average value (number) of viable cell count after storing the test piece on which the microparticles are coated for 24 hours.Type: ApplicationFiled: September 2, 2010Publication date: March 3, 2011Inventors: Kayo NAKANO, Akira Sato, Yasuhiro Shirakawa, Keiichi Fuse, Shinya Kasamatsu, Akito Sasaki
-
Publication number: 20110052721Abstract: Described is an intra-mammary teat sealant and a corresponding method of forming a physical barrier in the teat canal of a non-human animal for prophylactic treatment of mammary disorders during the animal's dry period. The method includes the step of infusing a bismuth-free teat seal formulation into the teat canal of the animal. The method also prevents the formation of black spot defect in dairy products, especially cheddar cheese, made from the milk of animals so treated.Type: ApplicationFiled: November 5, 2010Publication date: March 3, 2011Inventor: Scott A. Rankin
-
Publication number: 20110044908Abstract: The present invention provides methods for treating or limiting development of age-related macular degeneration, as well as methods for identifying compound suitable for such use.Type: ApplicationFiled: April 17, 2009Publication date: February 24, 2011Applicant: Arizona Board of Regents, a body Corporate of the State of Arizona, acting for and on behalf of theInventors: Brian McKay, John A. Martens
-
Publication number: 20110045070Abstract: The present invention provides a composition comprising zinc and trimethoprim, particularly in a weight ration of about 1:3 to about 1:7, as well as a sustained- or prolonged-release preparation which comprises trimethoprim and zinc and a biodegradable polymer providing a clinically useful composition which has prolonged release over a long period of time.Type: ApplicationFiled: February 27, 2009Publication date: February 24, 2011Inventor: Magdi El-Habbal
-
Publication number: 20110045052Abstract: The present invention relates to bioactive glass coatings. In particular, the present invention relates to bioactive glass coatings for Ti6Al4V alloys and chrome cobalt alloys, wherein the thermal expansion coefficient of the glass coating is matched to that of the alloy. Such coatings have a particular application in the field of medical prosthetics. The bioactive glass comprises (in mol %) 35-53 SiO2; 2-11 Na20; at least 2% of each of CaO, MgO and K20; 0-15 ZnO; 0-2 B202 and 0-9 P205.Type: ApplicationFiled: December 19, 2008Publication date: February 24, 2011Applicant: IMPERIAL INNOVATIONS LTD.Inventors: Robert Graham Hill, Molly Morag Stevens, Matthew O'Donnell
-
Patent number: 7887848Abstract: In an embodiment of the present invention, a nutraceutical formula comprising a combination of chromium, zinc, berry extract, Polygonum cuspidatum extract, aloe vera, chlorophyll and L-arginine combined synergistically to reduce inflammation in mammals suffering from diabetes. In another embodiment of the present invention, a nutraceutical formula comprising a of zinc, chromium, berry extract, Polygonum cuspidatum extract, aloe vera, chlorophyll and L-arginine combined synergistically to enhance wound healing in mammals suffering from diabetes. In an alternative embodiment of the present invention, a nutraceutical formula comprising a of zinc, chromium, berry extract, Polygonum cuspidatum extractive, aloe vera, chlorophyll and L-arginine combined synergistically to reduce inflammation in mammals not suffering from diabetes.Type: GrantFiled: May 31, 2007Date of Patent: February 15, 2011Assignee: Interhealth Nutraceuticals, Inc.Inventors: Xiaoming Xu Chien, Debasis Bagchi
-
Patent number: 7879365Abstract: The present invention provides for compositions and methods that may offer protection from irritants as well as antimicrobial protection. Preferred embodiments of the invention include topical antimicrobial compositions that lack conventional antibiotics or preservatives, wherein the antimicrobial benefit is created by essential oils (or their active ingredients), emollient solvents and, in some instances, anti-inflammatory agents.Type: GrantFiled: July 15, 2004Date of Patent: February 1, 2011Assignee: The Trustees of Columbia University in the City of New YorkInventors: Shanta M. Modak, Trupti Gaonkar, Milind Shintre, Lauserpina Caraos
-
Patent number: 7879367Abstract: The invention relates to a medical implant made of a metallic material. After fulfilling its temporary support function, the implant is degraded by corrosion at a predetermined rate. Negative long-term effects are thus avoided.Type: GrantFiled: July 17, 1998Date of Patent: February 1, 2011Assignees: Alfons Fischer, Jacqueline Hausdorf, Eva HeubleinInventors: Bernd Heublein, Gerd Hausdorf
-
Publication number: 20110014258Abstract: The present invention provides a coating comprising a bioactive material and an antimicrobial agent, wherein the concentration of said antimicrobial agent varies throughout the thickness of the coating.Type: ApplicationFiled: February 27, 2009Publication date: January 20, 2011Applicant: SMITH & NEPHEW, INC.Inventors: Lu Gan, Marcus L. Scott, Shilesh C. Jani, Laura S. Whitsitt
-
Publication number: 20110014277Abstract: Disclosed is a compound and methods for use by an individual attempting to reduce or cease tobacco smoking or one exposed to environmental tobacco smoke. The compound includes a first component blocking nicotine receptor sites to reduce nicotine cravings or withdrawal symptoms, a second component increasing serotonin levels and acting synergistically with the first component to reduce nicotine cravings or withdrawal symptoms, assisting in maintaining body weight and reducing increased stress and anxiety, and a third component acting synergistically with the first and/or second component to reduce nicotine cravings or withdrawal symptoms, maintain body weight, and/or reduce increased stress and anxiety. The third component comprises a supplement that replenishes depleted body substance(s), repairs damaged body substance(s), and/or ameliorates the impaired function of body substance(s). Some combination of the first, second, and third component alters the perceived taste of tobacco smoke.Type: ApplicationFiled: September 29, 2010Publication date: January 20, 2011Inventor: Harlan Clayton Bieley
-
Publication number: 20110008407Abstract: The present invention discloses a coating for a medical implant, wherein at least a part of said coating contains an osseointegration agent and the same and/or a different part of the coating contains an antimicrobial metal agent.Type: ApplicationFiled: February 27, 2009Publication date: January 13, 2011Applicant: SMITH & NEPHEW, INC.Inventors: Lu Gan, Marcus L. Scott, Shilesh C. Jani
-
Publication number: 20110008399Abstract: The present invention relates to compositions such as coatings, printing inks or cosmetics, which contain pigments comprising or consisting of a layer made of a material with an index of refraction that is higher than the index of refraction of the adjacent material by at least 0.25; whereas said layer has a zero-order diffractive micro-structure; whereas said layer acts as an optical waveguide and whereas said layer has a thickness between 50 nm and 500 nm; to processes for its manufacture and to its use. These pigments show a colour effect upon rotation and/or tilting, and it is believed that this colour effect is based on zero-order diffraction.Type: ApplicationFiled: November 19, 2008Publication date: January 13, 2011Applicant: BASF SEInventors: Philippe Bugnon, Hans Reichert, Alexander Stuck, Harald Walter
-
Patent number: 7867523Abstract: A pharmaceutical composition for the treatment of colds and influenza. The pharmaceutical composition is a mixture of: acetaminophen, diphenhydramine, dextromethorphan, arabinogalactan, vitamin C, zinc, olive leaf extract, resveratrol and elderberry extract.Type: GrantFiled: July 18, 2008Date of Patent: January 11, 2011Inventor: Elaine A. Vanterpool
-
Patent number: 7867522Abstract: Composition and methods for alleviating or eliminating wounds and/burns by providing an effective amount of one or more copper, zinc and copper-zinc compositions are disclosed. Treatment is accomplished through the use of topical compositions containing one or more copper or zinc salts and/or copper-zinc compounds or complexes, particularly copper-zinc malonate active ingredient.Type: GrantFiled: December 29, 2006Date of Patent: January 11, 2011Assignee: JR Chem, LLCInventors: Joseph R. Faryniarz, Jose E. Ramirez
-
Publication number: 20110002966Abstract: A vaginal suppository system contains a formulation comprising active and inactive ingredients, which active ingredients may be nutraceuticals, herbs, vitamins, minerals and other bioactive agents. In an embodiment, the active ingredients comprise Oak gall, true unicorn root, bitter orange peel, tropical almond, heartsease, and zinc oxide. The formulation may be contained in a soluble encapsulation or a suspension for administration of the formulation in a vagina. A method of preparing a vaginal suppository system and a method of treating a vagina with a formulation comprising active and inactive ingredients are also disclosed.Type: ApplicationFiled: June 24, 2010Publication date: January 6, 2011Inventors: Alex Lovett, Marge Siebert
-
Publication number: 20100330140Abstract: A facial mask for use in decreasing the transmission of one or more than one human pathogen to and from a human wearer of the facial mask, the facial mask comprising a facepiece; where the facepiece comprises three or more than three layers; where one or more than one of the three or more than three layers comprises a fabric comprising one or more than one binding substance comprising one or more than one human pathogen binding group for chemically attaching the human pathogen to the binding substance; where the fabric further comprises one or more than one type of multivalent metallic ion or metallic salt; and where one or more than one of the three or more than three layers comprises a heat-moldable fabric.Type: ApplicationFiled: June 25, 2008Publication date: December 30, 2010Applicant: FILLIGENT LIMITEDInventors: Neal G. Stewart, Lok Yuen Lo, Francis Chi Nan Lau, Dacey J. Ryan, Reid W. von Borstel
-
Publication number: 20100330171Abstract: Nutritional supplements for eye health comprising: an anti-oxidant component; an anti-inflammatory component; and an anti-angiogenic component. The supplements inhibit development and progression of a range of retinal diseases and degenerations, particularly AMD and diabetic eye disease, diabetic retinopathy and diabetic macular edema. The supplements include tocotrienol and green tea extract.Type: ApplicationFiled: January 21, 2010Publication date: December 30, 2010Inventors: Jeffrey P. Gilbard, Johanna M. Seddon
-
Publication number: 20100330197Abstract: The present invention provides an oral or enteral composition incorporating not only BCAA but other nutrients to be conducive to comprehensive recovery from fatigue, and improvement in total physical condition. The oral or enteral composition is formulated as a composite of a branched-chain amino acid, coenzyme Q10, L-carnitine, a citric acid, and zinc.Type: ApplicationFiled: February 19, 2009Publication date: December 30, 2010Applicants: EARNEST MEDICINE CO., LTD., OTSUKA PHARMACEUTICAL FACTORY, INC.Inventors: Takashi Higashiguchi, Takako Hatakeyama
-
Publication number: 20100330163Abstract: Methods and compositions are provided for increasing responsiveness to therapeutic metalloproteases including increasing and/or maximizing responsiveness and preventing botulinum and tetanus toxin resistance due to a functional deficiency of zinc. Also provided are methods for zinc replacement or supplement in lacking individuals comprising the administration of a zinc supplement for a loading period and/or administration of a phytase supplement together with the zinc supplement. Also provided are methods for standardization of botulinum toxin potency assays that provide for greater certainty and margins of safety in the use of products from different manufacturers.Type: ApplicationFiled: June 23, 2010Publication date: December 30, 2010Inventor: Charles N.S. Soparkar
-
Patent number: 7858124Abstract: The present invention relates to an anti-bacterial, anti-virus, and anti-fungus composition, its preparation and use. The composition of the present invention mainly includes the following three ingredients in an adequate ratio: (A) a metal compound having a catalytic function; (B) ionic compound, and (C) an additive. The anti-bacterial, anti-virus, and anti-fungus composition of the present invention is capable of destroying viruses as well as killing bacterial and fungi. Therefore, the composition can be formulated as an aerosol and a film for applying to protection devices such as respirators, masks, gloves, filters, condoms, etc. The present composition can also be used in household, vehicle, hospital, school, restaurant, hotel, internet coffee shop for applying to filter of air-conditioner, tap, stool, interior of elevator and its keyboard.Type: GrantFiled: April 7, 2008Date of Patent: December 28, 2010Assignee: Well-Being Biochemical Corp.Inventors: Jih Ru Hwu, Shwu Chen Tsay
-
Patent number: 7858602Abstract: A method for the treatment and prophylaxis of conditions of aging due oxidative stress and as growth factors of stem cells. Such conditions due to oxidative stress are associated with a decreased presence of one or more cell-specific carbonic anhydrase enzymes in the tissue of a subject. Such conditions include but are not limited to alzheimer's disease, parkinson's disease, multiple sclerosis, autism, lou gehrig's disease, huntington's disease, diabetes mellitus, amyloid diseases, atherosclerosis, arthritis, osteoporosis, cystic fibrosis. The method comprises administering to the patient a pharmaceutically effective, non-toxic amount of one or more compounds that increases the presence of one or more Carbonic Anhydrase Isozymes whose levels have been reduced in the subject.Type: GrantFiled: May 12, 2007Date of Patent: December 28, 2010Inventor: Victorio C. Rodriguez
-
Publication number: 20100323030Abstract: A composition for treating damaged tissue and promoting healthy tissue growth, healing and tissue regeneration, wherein said composition comprises an extracellular matrix compound, a surface-active lipid, one or more enantioinerically pure L-amino acids or glycine, a hydrophilic surfactant with a high HLB, as well as vitamins, minerals or trace elements. Not only does it maintain good health, but the components are non-intrusive, bio-safe, non-coalescent and can mimic normally occurring stem-cells within a body. When applied to diseased tissues, the subject compositions can stimulate, facilitate, and accelerate protein synthesis for the regeneration of diseased organs and tissues. The healing efficacy of these tissue components gives us further appreciation of the protective action of human tissue over and above and other than the immune protective system or perhaps an integral component part of the immune system.Type: ApplicationFiled: August 31, 2010Publication date: December 23, 2010Applicant: IMMUNOPATH PROFILE, INC.Inventor: Leonard S. Girsh
-
Publication number: 20100323031Abstract: The present disclosure discloses a synergistic combination comprising (?)-hydroxycitric acid, bitter melon extract and sesame seed lignans extract to enhance blood glucose and insulin metabolism. The synergistic combination also reduces reactive hypoglycemia in those who are insulin resistant.Type: ApplicationFiled: June 22, 2009Publication date: December 23, 2010Applicant: GLYKON TECHNOLOGIES GROUP, LLCInventors: Daniel Elliot Clouatre, Dallas Lavoe Clouatre
-
Publication number: 20100316733Abstract: A method of treating cancer concurrent with receiving chemotherapy treatments which may effectively ameliorate the anemic and toxic effects induced by chemotherapy includes prescribing at least three hyperbaric oxygen therapy treatments per week at a pressure of at least 1.5 ATA, the treatments lasting at least 30 minutes each, prescribing a diet including less than about 300 grams of carbohydrates a day, and prescribing nutritional supplements in accordance with a nutritional supplement regimen including elevated amounts of vitamin B-12, vitamin E, and zinc as compared to a reference daily intake.Type: ApplicationFiled: June 15, 2010Publication date: December 16, 2010Inventor: Kenneth R. Locklear